Xtx Topco LTD Novo Cure LTD Transaction History

Xtx Topco LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$11.83 - $24.05 $172,741 - $351,178	-14,602 Reduced 44.24%	18,407 $315,000
Q1 2024 May 13, 2024	SELL	$12.42 - $17.29 $173,470 - $241,489	-13,967 Reduced 29.73%	33,009 $515,000
Q4 2023 Feb 13, 2024	BUY	$11.13 - $15.78 $166,783 - $236,463	14,985 Added 46.84%	46,976 $701,000
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $516,654 - $1.35 Million	31,991 New	31,991 $516,000
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $225,477 - $474,645	3,995 New	3,995 $240,000
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $190,795 - $268,097	-3,172 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$75.08 - $121.99 $99,105 - $161,026	1,320 Added 71.27%	3,172 $238,000
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $215,146 - $360,306	1,852 New	1,852 $215,000
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $409,586 - $708,546	-3,141 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $389,829 - $597,323	3,141 New	3,141 $415,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.